Technical analysis of Accuray Incorporated (ARAY): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Accuray Incorporated specializes in the design, development, production, and sale of advanced radiosurgery and radiation therapy equipment aimed at treating tumors. Their market footprint spans across North and South America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and the broader Asia Pacific region.
Price Performance
| 1 month | -22.29% |
| 3 months | -29.63% |
| Year-to-date | -70.31% |
| 1 year | -84.60% |
| 3 years | -90.97% |
52-Week Range
| 52-week High | $2.10 |
| 52-week Low | $0.22 |
| Avg Volume (90d) | 2.5M |
Technical Indicators
| SMA 50 | $0.27 |
| SMA 200 | $0.48 |
| Beta | 1.32 |
| 30-day Volatility (annualised) | 67.5% |
| Price vs SMA 50 | -7.7% |
| Price vs SMA 200 | -49.1% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $1.41 | |
| 2025-11 | $1.08 | -23.4% |
| 2025-12 | $0.82 | -23.6% |
| 2026-01 | $0.81 | -2.1% |
| 2026-02 | $0.58 | -28.5% |
| 2026-03 | $0.39 | -32.8% |
| 2026-04 | $0.47 | +20.3% |
| 2026-05 | $0.38 | -19.0% |
| 2026-06 | $0.26 | -31.9% |
| 2026-07 | $0.27 | +4.0% |
| 2026-08 | $0.26 | -1.9% |
| 2026-09 | $0.24 | -6.9% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-15 | | $42M |
| 2026-09-15 | $0.04 | $67M |
| 2026-09-15 | | $71M |
| 2026-09-15 | | |
| 2026-09-15 | $0.13 | $458M |
| 2026-09-15 | | |
Price
| Price | $0.24 |
| Market Cap | $29M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 0.67 |
| EV / EBITDA | -12.16 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 4.41 |
| Current Ratio | 1.50 |